| Bioactivity | Mal-PEG8-Val-Ala-PAB-SB-743921 (Compound D7) is a Drug-Linker Conjugates for ADC. Mal-PEG8-Val-Ala-PAB-SB-743921 consists of KSP inhibitor SB-743921 (HY-14661) and a linker. Mal-PEG8-Val-Ala-PAB-SB-743921 can be used for synthesis of ADCs[1]. |
| Name | Mal-PEG8-Val-Ala-PAB-SB-743921 |
| Formula | C73H96ClN7O19 |
| Molar Mass | 1411.03 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Li Y, et al. A novel antibody-KSP inhibitor conjugate improves KSP inhibitor efficacy in vitro and in vivo. Biomaterials. 2023 Jul 28;301:122258. |
Mal-PEG8-Val-Ala-PAB-SB-743921
CAS: F: C73H96ClN7O19 W: 1411.03
Mal-PEG8-Val-Ala-PAB-SB-743921 (Compound D7) is a Drug-Linker Conjugates for ADC. Mal-PEG8-Val-Ala-PAB-SB-743921 consist
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.